128 related articles for article (PubMed ID: 38387169)
1. Generation of IPi001-A/B/C human induced pluripotent stem cell lines from healthy amniotic fluid cells.
Boullé M; Boucharlat A; Leleu A; Banal C; Coussement A; Hollenstein M; Yates F; Lefort N; Agou F
Stem Cell Res; 2024 Apr; 76():103350. PubMed ID: 38387169
[TBL] [Abstract][Full Text] [Related]
2. Generation of iPSC lines from primary human amniotic fluid cells.
Drews K; Matz P; Adjaye J
Stem Cell Res; 2015 Nov; 15(3):712-4. PubMed ID: 26987930
[TBL] [Abstract][Full Text] [Related]
3. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
4. Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette.
Fan Y; Luo Y; Chen X; Li Q; Sun X
J Reprod Dev; 2012; 58(4):404-9. PubMed ID: 22498813
[TBL] [Abstract][Full Text] [Related]
5. Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.
Jiang G; Herron TJ; Di Bernardo J; Walker KA; O'Shea KS; Kunisaki SM
Stem Cells Transl Med; 2016 Dec; 5(12):1595-1606. PubMed ID: 27465073
[TBL] [Abstract][Full Text] [Related]
6. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
7. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications.
Moraghebi R; Kirkeby A; Chaves P; Rönn RE; Sitnicka E; Parmar M; Larsson M; Herbst A; Woods NB
Stem Cell Res Ther; 2017 Aug; 8(1):190. PubMed ID: 28841906
[TBL] [Abstract][Full Text] [Related]
8. Generation of two induced pluripotent stem cell lines IMAGINi004-A and IMAGINi005-A from healthy donors.
Quelennec E; Banal C; Hamlin M; Clémantine D; Michael M; Lefort N
Stem Cell Res; 2020 Oct; 48():101959. PubMed ID: 32866896
[TBL] [Abstract][Full Text] [Related]
9. Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease.
Yan JM; Li DZ
Hemoglobin; 2017 May; 41(3):198-202. PubMed ID: 28835139
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.
Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I
Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cells from human amniotic fluid cells by reprogramming with two factors in feeder-free conditions.
Li Q; Fan Y; Sun X; Yu Y
J Reprod Dev; 2013; 59(1):72-7. PubMed ID: 23138118
[TBL] [Abstract][Full Text] [Related]
13. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).
Spinelli V; Guillot PV; De Coppi P
Organogenesis; 2013; 9(2):101-10. PubMed ID: 23823661
[TBL] [Abstract][Full Text] [Related]
15. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid as a source of pluripotent and multipotent stem cells for organ regeneration.
Da Sacco S; De Filippo RE; Perin L
Curr Opin Organ Transplant; 2011 Feb; 16(1):101-5. PubMed ID: 21157345
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.
Meshrkey F; Scheulin KM; Littlejohn CM; Stabach J; Saikia B; Thorat V; Huang Y; LaFramboise T; Lesnefsky EJ; Rao RR; West FD; Iyer S
Stem Cell Res Ther; 2023 Nov; 14(1):320. PubMed ID: 37936209
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of an internal control for directed differentiation using pluripotent stem cell lines derived from heterozygotic twins].
Luo YM; Fan Y; Chen XJ; Yue L; Li Q; He WZ; Ma XY; Zheng YH; Sun XF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):398-403. PubMed ID: 22875494
[TBL] [Abstract][Full Text] [Related]
19. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
[TBL] [Abstract][Full Text] [Related]
20. Generation of control iPSC lines CBRCULi008-A and CBRCULi009-A derived from lymphoblastoid cell lines.
Chapotte-Baldacci CA; Jauvin D; Chahine M
Stem Cell Res; 2023 Sep; 71():103168. PubMed ID: 37473461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
